News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Jingchuan Zhang

Articles by Jingchuan Zhang

9 Real-world Treatment Patterns and Clinical Outcomes in Patients Treated With Eribulin After Prior Immunotherapy (IO) or Antibody-Drug Conjugate (ADC) for Metastatic Breast Cancer

ByRavi K. Goyal,Jingchuan Zhang,Samina Dhuliawala,Martina Sluga-O’Callaghan,Peter A. Kaufman, MD

April 18th 2022

Latest Updated Articles

9 Real-world Treatment Patterns and Clinical Outcomes in Patients Treated With Eribulin After Prior Immunotherapy (IO) or Antibody-Drug Conjugate (ADC) for Metastatic Breast Cancer
Published: April 18th 2022 | Updated:

Trending on CancerNetwork

ASH 2025: Which Presentations Will Move the Multiple Myeloma Needle?

ASH 2025: Key Anticipated Updates in the Leukemia Landscape

FDA and EMA Clear Phase 3 POLARIS-1 Trial in Newly Diagnosed Ph+ ALL

Outlining Emergent Research in the EGFR-Mutated Lung Cancer Space

FDA Approves Liso-Cel in Marginal Zone Lymphoma After 2 Lines of Therapy

© 2025 MJH Life Sciences^®

All rights reserved.